Basic research studies to understand aneurysm disease

Drug News and Perspectives

Volumn 21, Issue 3, 2008, Pages 142-148

  Boddy, Amy M ^a   Lenk, Guy M ^a   Lillvis, John H ^a   Nischan, Jennifer ^a   Kyo, Yoshiki ^b   Kuivaniemi, Helena ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; AMLODIPINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; AZELNIDIPINE; BATIMASTAT; CELECOXIB; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; ESTRADIOL; FASUDIL; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; MATRIX METALLOPROTEINASE INHIBITOR; METACEPT 1; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; OLIGODEOXYNUCLEOTIDE DERIVATIVE; POLYPHENOL DERIVATIVE; PROPRANOLOL DERIVATIVE; PYRROLIDINE DITHIOCARBAMATE; RAPAMYCIN; ROFECOXIB; RS 132908; SIMVASTATIN; TAMOXIFEN; TETRACYCLINE DERIVATIVE;

ABDOMINAL AORTA ANEURYSM; APOPTOSIS; CELL LOSS; DENDRITIC CELL; DISEASE COURSE; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOME ANALYSIS; HUMAN; MEDICAL RESEARCH; MICROARRAY ANALYSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MATRIX METALLOPROTEINASES; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS;

EID: 44949161150     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.3.1203410     Document Type: Review

References (67)

1. Diehm, N., Dick, F., Schaffner, T. et al. Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts. Prog Cardiovasc Dis 2007, 50(3): 209-17.
2. Lillvis, J.H., Lenk, G.M. and Kuivaniemi, H. Genetics of abdominal aortic aneurysms. In: Aortic Aneurysms: Pathogenesis and Treatment. G. Upchurch, E. Criado (Eds.). Humana Press Inc., Totowa, NJ, in press.
3. Kuivaniemi, H., Platsoucas, C.D. and Tilson III, M.D. Aortic aneurysms: An immune disease with a strong genetic component. Circulation 2008, 117(2): 242-52.
4. Ogata, T., MacKean, G.L., Cole, C.W., Arthur, C., Andreou, P., Tromp, G. and Kuivaniemi, H. The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia, Canada. J Vasc Surg 2005, 42(5): 891-7.
5. Norman, P.E. and Powell, J.T. Abdominal aortic aneurysm: The prognosis in women is worse than in men. Circulation 2007, 115(22): 2865-9.
6. LaMorte, W.W., Scott, T.E. and Menzoian, J.O. Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: Relationship to cardiovascular risk factors. J Vasc Surg 1995, 21(3): 422-31.
7. Sandford, R.M., Bown, M.J., London, N.J. and Sayers, R.D. The genetic basis of abdominal aortic aneurysms: A review. Eur J Vasc Endovasc Surg 2007, 33(4): 381-90.
8. Helgadottir, A., Thorleifsson, G., Magnusson, K.P. et al. A sequence variant on chromosome 9p21 confers risk of both abdominal aortic aneurysm and intracranial aneurysm in addition to coronary artery disease. Nat Genet 2008, in press.
9. Broadbent, H.M., Peden, J.F., Lorkowski, S. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked, SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17(6): 806-14.
10. Shibamura, H., Olson, J.M., van Vlijmen-Van Keulen, C. et al. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 2004, 109(17): 2103-8.
11. Van Vlijmen-Van Keulen, C.J., Rauwerda, J.A. and Pals, G. Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. Eur J Vasc Endovasc Surg 2005, 30(1): 29-35.
12. Bobryshev, Y.V. and Lord, R.S. Vascularassociated lymphoid tissue (VALT) involvement in aortic aneurysm. Atheroscler 2001, 154(1): 15-21.
13. Koch, A.E., Haines, G.K., Rizzo, R.J., Radosevich, J.A., Pope, R.M., Robinson, P.G. and Pearce, W.H. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990, 137(5): 1199-213.
14. Galle, C., Schandene, L., Stordeur, P. et al. Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol 2005, 142(3): 519-27.
15. Ocana, E., Bohorquez, J.C., Perez-Requena, J., Brieva, J.A. and Rodriguez, C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 2003, 170(1): 39-48.
16. Platsoucas, C.D., Lu, S., Nwaneshiudu, I. et al. Abdominal aortic aneurysm is a specific antigen-driven T cell disease. Ann N Y Acad Sci 2006, 1085: 224-35.
17. Bobryshev, Y.V., Lord, R.S. and Parsson, H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg 1998, 6(3): 240-9.
18. Chan, W.L., Pejnovic, N., Hamilton, H., Liew, T.V., Popadic, D., Poggi, A. and Khan, S.M. Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells. Circ Res 2005, 96(6): 675-83.
19. Chan, W.L., Pejnovic, N., Liew, T.V. and Hamilton, H. Predominance of Th2 response in human abdominal aortic aneurysm: Mistaken identity for IL-4-producing NK and NKT cells? Cell Immunol 2005, 233(2): 109-14.
20. Tsuruda, T., Kato, J., Hatakeyama, K. et al. Adrenomedullin in mast cells of abdominal aortic aneurysm. Cardiovasc Res 2006, 70(1): 158-64.
21. Lenk, G.M., Tromp, G., Weinsheimer, S., Gatalica, Z., Berguer, R. and Kuivaniemi, H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007, 8: 237.
22. Middleton, R.K., Lloyd, G.M., Bown, M.J., Cooper, N.J., London, N.J. and Sayers, R.D. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study. J Vasc Surg 2007, 45(3): 574-80.
23. Hannawa, K.K., Eliason, J.L., Woodrum, D.T. et al. L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 2005, 112(2): 241-7.
24. Pagano, M.B., Bartoli, M.A., Ennis, T.L., Mao, D., Simmons, P.M., Thompson, R.W. and Pham, C.T. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci U S A 2007, 104(8): 2855-60.
25. Sun, J., Sukhova, G.K., Yang, M. et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007, 117(11): 3359-68.
26. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. and Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121(11): 2381-6.
27. Leuner, K., Pantel, J., Frey, C. et al. Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J Neural Transm Suppl 2007, 72: 207-15.
28. Pennathur, S. and Heinecke, J.W. Oxidative stress and endothelial dysfunction in vascular disease. Curr Diab Rep 2007, 7(4): 257-64.
29. McCormick, M.L., Gavrila, D. and Weintraub, N.L. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2007, 27(3): 461-9.
30. Szasz, T., Thakali, K., Fink, G.D. and Watts, S.W. A comparison of arteries and veins in oxidative stress: Producers, destroyers, function, and disease. Exp Biol Med (Maywood) 2007, 232(1): 27-37.
31. D'Autreaux, B. and Toledano, M.B. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8(10): 813-24.
32. Dalman, R.L. Oxidative stress and abdominal aneurysms: How aortic hemodynamic conditions may influence AAA disease. Cardiovasc Surg 2003, 11(5): 417-9.
33. Marumo, T., Schini-Kerth, V.B., Fisslthaler, B. and Busse, R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 1997, 96(7): 2361-7.
34. Lum, H. and Roebuck, K.A. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001, 280(4): C719-41.
35. Dimmeler, S. and Zeiher, A.M. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept 2000, 90(1-3): 19-25.
36. Rajagopalan, S., Meng, X.P., Ramasamy, S., Harrison, D.G. and Galis, Z.S. Reactive oxygen species produced by macrophagederived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98(11): 2572-9.
37. Henderson, E.L., Geng, Y.J., Sukhova, G.K., Whittemore, A.D., Knox, J. and Libby, P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99(1): 96-104.
38. Bennett, M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999, 41(2): 361-8.
39. Lindeman, J.H., Abdul-Hussien, H., Schaapherder, A.F., van Bockel, J.H., von der Thusen, J.H., Roelen, D.L. and Kleemann, R. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurismal from atherosclerotic aorta: IL-6 and IL-8 dominated inflammatory responses prevail in the human aneurysm. Clin Sci (Lond) 2007, Dec 13, Advance publication.
40. Sho, E., Sho, M., Nanjo, H., Kawamura, K., Masuda, H. and Dalman, R.L. Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms. J Vasc Surg 2005, 41(5): 844-52.
41. Wang, Y.X., Martin-McNulty, B., da Cunha, V. et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 2005, 111(17): 2219-26.
42. Moran, C.S., McCann, M., Karan, M., Norman, P., Ketheesan, N. and Golledge, J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005, 111(23): 3119-25.
43. Zhang, J., Bockler, D., Ryschich, E., Klemm, K., Schumacher, H., Schmidt, J. and Allenberg, J.R. Impaired Fas-induced apoptosis of T lymphocytes in patients with abdominal aortic aneurysms. J Vasc Surg 2007, 45(5): 1039-46.
44. Aziz, F. and Kuivaniemi, H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg 2007, 21(3): 392-401.
45. Sakalihasan, N., Limet, R. and Defawe, O.D. Abdominal aortic aneurysm. Lancet 2005, 365(9470): 1577-89.
46. Wilson, W.R.W., Anderton, M., Schwalbe, E.C., Jones, J.L., Furness, P.N., Bell, P.R.F. and Thompson, M.M. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 2006, 113(3): 438-45.
47. Keeling, W.B., Armstrong, P.A., Stone, P.A., Bandyk, D.F. and Shames, M.L. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005, 39(6): 457-64.
48. Galis, Z.S. and Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenes is: The good, the bad, and the ugly. Circ Res 2002, 90(3): 251-62.
49. Raffetto, J.D. and Khalil, R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75(2): 346-59.
50. Pyo, R., Lee, J.K., Shipley, J.M., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105(11): 1641-9.
51. Longo, G.M., Xiong, W., Greiner, T.C., Zhao, Y., Fiotti, N. and Baxter, B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002, 110(5): 625-32.
52. Qin, X., Corriere, M.A., Matrisian, L.M. and Guzman, R.J. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006, 26(7): 1510-6.
53. Bigatel, D.A., Elmore, J.R., Carey, D.J., Cizmeci-Smith, G., Franklin, D.P. and Youkey, J.R. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg 1999, 29(1): 130-8.
54. Petrinec, D., Liao, S., Holmes, D.R., Reilly, J.M., Parks, W.C. and Thompson, R.W. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996, 23(2): 336-46.
55. Isenburg, J.C., Simionescu, D.T., Starcher, B.C. and Vyavahare, N.R. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 2007, 115(13): 1729-37.
56. Vinh, A., Gaspari, TA., Liu, H.B., Dousha, L.F., Widdop, R.E. and Dear, A.E. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J Vasc Res 2007, 45(2): 143-52.
57. Yokokura, H., Hiromatsu, S., Akashi, H., Kato, S. and Aoyagi, S. Effects of calcium channel blocker azelnidipine on experimental abdominal aortic aneurysms. Surg Today 2007, 37(6): 468-73.
58. Armstrong, P.J., Franklin, D.P., Carey, D.J. and Elmore, J.R. Suppression of experimen tal aortic aneurysms: Comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann Vasc Surg 2005, 19(2): 248-57.
59. Miralies, M., Wester, W., Sicard, G.A., Thompson, R. and Reilly, J.M. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999, 29(5): 884-92.
60. King, V.L., Trivedi, D.B., Gitlin, J.M. and Loftin, C.D. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol 2006, 26(5): 1137-43.
61. Lawrence, D.M., Singh, R.S., Franklin, D.P., Carey, D.J. and Elmore, J.R. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 2004, 40(2): 334-8.
62. Johanning, J.M., Armstrong, P.J., Franklin, D.P., Han, D.C., Carey, D.J. and Elmore, J.R. Nitric oxide in experimental aneurysm formation: Early events and consequences of nitric oxide inhibition. Ann Vasc Surg 2002, 16(1): 65-72.
63. Parodi, F.E., Mao, D., Ennis, T.L., Bartoli, M.A. and Thompson, R.W. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. J Vasc Surg 2005, 41(3): 479-89.
64. Miyake, T., Aoki, M., Nakashima, H. et al. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Gene Ther 2006, 13(8): 695-704.
65. Brophy, C., Tilson, J.E. and Tilson, M.D. Propranolol delays the formation of aneurysms in the male blotchy mouse. J Surg Res 1988, 44(6): 687-9.
66. Martin-McNulty, B., Tham, D.M., da Cunha, V. et al. 17Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23(9): 1627-32.
67. Grigoryants, V., Hannawa, K.K., Pearce, C.G. et al. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg 2005, 41(1): 108-14.